31 Mar 2021
Assets44.62
Total Income82.42
Profit After Tax10.34
NET Worth-7.86
Reserves and Surplus-12.76
Total Borrowing32.93
Open · Close · Listing
Ambey Laboratories is a SME IPO with an issue size of ₹44.68 crore, proposed for listing on NSE SME. The issue structure includes a fresh issue of ₹40.31 crore and an offer-for-sale component of ₹2.12 crore.
| Object | Amount |
|---|---|
| To meet out the Working Capital requirements | ₹30.93 Cr |
| To meet out the General Corporate Purposes | ₹9.12 Cr |
| Issue Expenses | ₹2.50 Cr |
| KPI | Jan 31, 2024 |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt / Equity | 0.58% |
| RoNW | 20.80% |
| PAT Margin | 6.01% |
| Price to Book Value | 3.58 |
| Expense | Amount |
|---|---|
| To meet out the Working Capital requirements | ₹30.93 Cr |
| To meet out the General Corporate Purposes | ₹9.12 Cr |
| Issue Expenses | ₹2.50 Cr |